Cellares will automate the TSC-101 manufacturing and testing processes on the Cell Shuttle and the Cell Q automated testing system.

Researchers discover manikomycin, a novel antibiotic that kills drug-resistant bacteria by targeting a previously unknown ribosomal target.

Researchers have uncovered a previously underappreciated mechanism that helps immune cells respond rapidly to infections.

Novel stem cell separation technologies target scalable bioprocessing with improved yield, viability, and therapeutic consistency.

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through ...

Dr. George is a physician-scientist whose clinical expertise is in disorders of hemostasis and thrombosis with a particular interest in hemophilia and hemophilia gene therapy. Her basic science ...

Early results reveal how a single‑cell spatial platform maps stromal barriers that limit antibody delivery and target engagement in human solid tumors.

Fulcrum Therapeutics said today it is scrapping its lead pipeline program to develop pociredir as a treatment for sickle cell disease (SCD) and launching a “comprehensive” review of strategic ...

Cellular phase separation may play a previously underappreciated role in regulating kinase activity, offering therapeutic ...

Researchers suggest study is the first to translate cell-free biomanufacturing from laboratory to real-world use, across multiple geographic settings.

Crystalys Therapeutics has dosed the first patient with its once daily oral, URAT1 inhibitor dotinurad in its Phase II AMETHYST trial (NCT07535034), designed to assess dotinurad’s effectiveness in ...

Neuropixels Opto is a single probe combining electrophysiology and optogenetics that simultaneously records and controls ...